Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMI-1271 in Calf-Level Deep Venous Thrombosis
NCT02744833Phase 2Terminated
- Sponsor
- GlycoMimetics
- Start
- Jul 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of uproleselan in deep vein thrombosis (DVT), sponsored by GlycoMimetics. Started Jul 2016; status: terminated.
02
Drugs
uproleselan
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02744833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744833.